192 related articles for article (PubMed ID: 25128769)
1. Arsenic decreases antinociceptive activity of paracetamol: possible involvement of serotonergic and endocannabinoid receptors.
Vijayakaran K; Kesavan M; Kannan K; Sankar P; Tandan SK; Sarkar SN
Environ Toxicol Pharmacol; 2014 Sep; 38(2):397-405. PubMed ID: 25128769
[TBL] [Abstract][Full Text] [Related]
2. Arsenic reduces the antipyretic activity of paracetamol in rats: modulation of brain COX-2 activity and CB₁ receptor expression.
Vijayakaran K; Kannan K; Kesavan M; Suresh S; Sankar P; Tandan SK; Sarkar SN
Environ Toxicol Pharmacol; 2014 Jan; 37(1):438-47. PubMed ID: 24448467
[TBL] [Abstract][Full Text] [Related]
3. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors.
Dogrul A; Seyrek M; Akgul EO; Cayci T; Kahraman S; Bolay H
Eur J Pharmacol; 2012 Feb; 677(1-3):93-101. PubMed ID: 22206817
[TBL] [Abstract][Full Text] [Related]
4. Influence of repeated preexposure to arsenic on acetaminophen-induced oxidative stress in liver of male rats.
Manimaran A; Sarkar SN; Sankar P
Food Chem Toxicol; 2010 Feb; 48(2):605-10. PubMed ID: 19932728
[TBL] [Abstract][Full Text] [Related]
5. Subacute arsenic exposure through drinking water reduces the pharmacodynamic effects of ketoprofen in male rats.
Ahmad W; Prawez S; Chanderashekara HH; Tandan SK; Sankar P; Sarkar SN
Environ Toxicol Pharmacol; 2012 Mar; 33(2):267-76. PubMed ID: 22236721
[TBL] [Abstract][Full Text] [Related]
6. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain.
Pini LA; Sandrini M; Vitale G
Eur J Pharmacol; 1996 Jul; 308(1):31-40. PubMed ID: 8836629
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats.
Sandrini M; Vitale G; Ruggieri V; Pini LA
Inflamm Res; 2007 Apr; 56(4):139-42. PubMed ID: 17522810
[TBL] [Abstract][Full Text] [Related]
9. Naloxone-reversible antinociception by paracetamol in the rat.
Pini LA; Vitale G; Ottani A; Sandrini M
J Pharmacol Exp Ther; 1997 Feb; 280(2):934-40. PubMed ID: 9023309
[TBL] [Abstract][Full Text] [Related]
10. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
Björkman R
Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
[TBL] [Abstract][Full Text] [Related]
11. Effect of nicotine pretreatment on arsenic-induced oxidative stress in male Wistar rats.
Pachauri V; Flora SJ
Hum Exp Toxicol; 2013 Sep; 32(9):972-82. PubMed ID: 23475432
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen-induced antinociception via central 5-HT(2A) receptors.
Srikiatkhachorn A; Tarasub N; Govitrapong P
Neurochem Int; 1999 Jun; 34(6):491-8. PubMed ID: 10402224
[TBL] [Abstract][Full Text] [Related]
13. Inorganic arsenic exposure affects pain behavior and inflammatory response in rat.
Aguirre-Bañuelos P; Escudero-Lourdes C; Sanchez-Peña LC; Del Razo LM; Perez-Urizar J
Toxicol Appl Pharmacol; 2008 Jun; 229(3):374-85. PubMed ID: 18329681
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.
Barrière DA; Mallet C; Blomgren A; Simonsen C; Daulhac L; Libert F; Chapuy E; Etienne M; Högestätt ED; Zygmunt PM; Eschalier A
PLoS One; 2013; 8(8):e70690. PubMed ID: 23940628
[TBL] [Abstract][Full Text] [Related]
15. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism.
Bonnefont J; Alloui A; Chapuy E; Clottes E; Eschalier A
Anesthesiology; 2003 Oct; 99(4):976-81. PubMed ID: 14508334
[TBL] [Abstract][Full Text] [Related]
16. Role of dietary GSH in the amelioration of sodium arsenite-induced ovarian and uterine disorders.
Chattopadhyay S; Ghosh D
Reprod Toxicol; 2010 Nov; 30(3):481-8. PubMed ID: 20580664
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol.
Ruggieri V; Vitale G; Pini LA; Sandrini M
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):219-29. PubMed ID: 18404260
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat.
Rodríguez VM; Limón-Pacheco JH; Carrizales L; Mendoza-Trejo MS; Giordano M
Neurotoxicol Teratol; 2010; 32(6):640-7. PubMed ID: 20699118
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary co-administration of sodium selenite on sodium arsenite-induced ovarian and uterine disorders in mature albino rats.
Chattopadhyay S; Pal Ghosh S; Ghosh D; Debnath J
Toxicol Sci; 2003 Oct; 75(2):412-22. PubMed ID: 12883085
[TBL] [Abstract][Full Text] [Related]
20. Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception.
Dogrul A; Seyrek M; Yalcin B; Ulugol A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):97-105. PubMed ID: 22300745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
